Related Experiment Videos
[Complement 3 in hypertension and arteriosclerosis]
Insights
Individuals with the C3F allotype may experience faster coronary atherosclerosis progression, especially when hypertension is also present. This genetic factor impacts complement component 3 activity and disease severity.
Area of Science:
- Immunogenetics
- Cardiovascular Disease Research
- Complement System Biology
Background:
- Hypertensive disease (HD) and coronary atherosclerosis (CA) are significant cardiovascular risks.
- The complement system, particularly complement component 3 (C3), plays a role in inflammatory processes relevant to cardiovascular health.
- Genetic variations, such as C3 allotypes, may influence disease susceptibility and progression.
Purpose of the Study:
- To investigate the association between C3 allotypes, serum C3 levels, and residual functional activity (RFA) in patients with hypertensive disease and/or coronary atherosclerosis.
- To determine if the C3F allotype is linked to an increased risk or accelerated progression of cardiovascular conditions.
- To explore differences in C3 parameters between patient groups and healthy controls.
Main Methods:
- Serum samples were collected from patients with HD, CA, HD + CA, and healthy controls.
- Measurements included serum C3 concentrations, C3 residual functional activity (RFA), and C3 allotype phenotyping.
- Statistical analyses were performed to compare groups and identify significant associations.
Main Results:
- A higher frequency of the C3F allotype was observed in patients with HD, CA, and HD + CA compared to controls.
- The combined HD + CA group exhibited a significant decrease in C3 RFA compared to the HD and CA groups alone.
- Significant differences in serum C3 concentrations and RFA were found in C3F carriers between CA and HD patients.
Conclusions:
- Carriage of the C3F allotype may predispose individuals to accelerated coronary atherosclerosis progression, particularly in the context of hypertensive disease.
- C3 RFA is significantly reduced in patients with both HD and CA, suggesting a role for complement dysfunction in combined disease states.
- The C3F allotype represents a potential genetic risk factor influencing the interplay between hypertension and atherosclerosis.
Abstract:
The serum levels, residual functional activity (RFA), phenotype of complement component 3 (C3) were determined in 20 patients with hypertensive disease (HD), 11 with documented coronary atherosclerosis (CA), and 11 with HD + CA. The sera from 21 apparently healthy subjects were used as a control. There was a higher frequency of the allotype C3F in the HD, CA, and HD + CA groups (0.400, 0.417, and 0.364, respectively) than in the controls. The HD + CA group showed a significant (p less than 0.05) decrease in RFA of C3 as compared to the HD and CA groups. There were significant differences in the serum C3 concentrations and RFA in allotype C3F carriers between the patients with CA and HD. The findings suggest that allotype C3F carriage may be a factor predisposing to accelerated progression of CA in HD.